Document is current
Any future updates will be listed below
-
Authors
Best, Christoph
Sayegh, Ana L.
Mueck, Anna
Emde, Julia
Thieme, Kati
Krämer, Heidrun H.
-
Funding
Funding for this research was provided by:
Justus-Liebig-Universität Gießen
- License Information
-
More Information
Article History
Received: 17 September 2025
Accepted: 28 November 2025
First Online: 5 December 2025
Declarations
:
: Written and informed consent was obtained from all subjects according to the declaration of Helsinki. The study was approved by the local Ethics Committees of the Philipps-University Marburg and the Justus-Liebig-University Giessen.
: Not applicable.
: C.B.: received lecturing honoraria and consulting fees from Novartis, Bayer and Portola, all unrelated to this publication. A.L.S.: no conflicts of interest are declared. A.M.: no conflicts of interest are declared. J.E.: no conflicts of interest are declared. K.T.: received BMBF (13GW0342B) grant and other grants for her research and the pain clinic at Philipps-University Marburg. H.H.K.: received travel grants from Alexion, Sanofi and Grifols, lecturing honoraria and consulting fees from Sanofi, Alexion, Roche, Argenx, UCB and Amgen and research support from Roche and Argenx, all unrelated to this publication.
